Skip to main content
SpringerLink
Log in

Will the Biden administration ‘follow the science’ on regulatory reform?

  • Correspondence
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Arlington, VA, USA

    John J. Cohrssen

  2. The Pacific Research Institute, San Francisco, CA, USA

    Henry I. Miller

Authors
  1. John J. Cohrssen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Henry I. Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John J. Cohrssen.

Ethics declarations

Competing interests

J.J.C. served in senior positions for White House agencies, including as Counsel to the White House Working Group that prepared the 1986 Coordinated Framework for the Regulation of Biotechnology, and is in private legal practice. H.I.M. was the founding director of the FDA’s Office of Biotechnology and is a senior fellow at the Pacific Research Institute.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cohrssen, J.J., Miller, H.I. Will the Biden administration ‘follow the science’ on regulatory reform?. Nat Biotechnol 39, 1334–1335 (2021). https://doi.org/10.1038/s41587-021-01084-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41587-021-01084-2

  • Springer Nature America, Inc.

Search

Navigation